Integrating machine learning and pharmacogenomics for biomarker discovery, identification and prioritization of potential drug candidates in ovarian cancer
{{output}}
Ovarian cancer remains a major global health concern and leading cause of mortality among women due to late diagnosis, therapeutic resistance, and limited predictive biomarkers for treatment response. There is an urgent need for integrative approaches to impro... ...
